EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Metabolic bariatric surgery generates substantial, sustained weight loss and health improvement in a real‐world setting

Wendy A Brown iD, Dianne L Brown, Jennifer F Holland, Angus Campbell, Jenifer Cottrell, Susannah Ahern iD, Jennifer Reilly iD, Patrick Garduce, James Wetter, Jeffrey M Hamdorf, Michael Talbot, Samuel Baker und 2 weitere

ANZ Journal of Surgery · 2025

DOI: 10.1111/ans.19378 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift ANZ Journal of Surgery, 2025. Verfasst von Wendy A Brown und 13 weiteren Autor:innen. Beteiligte Einrichtung: Bariatric Surgery Registry, Central Clinical School, Monash University, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Bariatric Surgery, Obesity, Morbid, Weight Loss. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Australian Government, Applied Medical, Johnson and Johnson.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To determine if the positive outcomes from clinical trials regarding the safety and efficacy of metabolic bariatric surgery are reproducible at a national level.

Methods

A longitudinal registry‐based observation study with data collected from all persons undergoing metabolic bariatric surgery in Australia from 28 February 2012–31 December 2021 including data from 122,567 index patients who underwent 134,625 completed bariatric procedures. Main Outcomes and Measures Defined adverse outcomes at 90‐days (unplanned readmission, intensive care admission and re‐operation; death), annual change in weight (percent total body weight loss (TBWL)), diabetes treatment and need for re‐operation.

Results

79.0% of participants were female. Mean age on the day of surgery was 44.0 years (SD 11.8; range 12.9‐87.9 years) and mean BMI 41.7 kg/m2 (SD 7.6). At 5‐years participants who underwent one anastomosis gastric bypass had TBWL 34.88% (SD 8.67%), roux‐en‐Y gastric bypass 30.73 % (SD 9.47%); sleeve gastrectomy 26.5% (SD 10.5%) and adjustable gastric bands 17.6% (SD 12.1%). At 90‐days 3.6% of procedures recorded a defined adverse event. 13,904 (13.6%) primary participants reported being treated for diabetes at baseline. No medication for diabetes was required by 71.6% (follow‐up 58%) at 1‐year and 61% (follow‐up 22%) at 5‐years. 13 904 (13.6%) primary participants reported being treated for diabetes at baseline. No medication for diabetes was required by 71.6% (follow‐up 58%) at 1‐year and 61% (follow‐up 22%) at 5‐years.

Conclusions

Metabolic bariatric surgery is safe and induces substantial weight loss with reduced need for diabetes medications in the real‐world. ClinicalTrials.gov ID NCT03441451.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bariatric SurgeryObesity, MorbidWeight LossAdolescentAdultAgedAged, 80 and overChildFemaleHumansMaleMiddle AgedYoung AdultAustraliaBody Mass IndexLongitudinal StudiesRegistriesTreatment Outcome

Stichwörter der Autor:innen

metabolic bariatric surgeryoutcomesquality and safetyregistryweight loss

Autor:innen und Institutionen

  • Bariatric Surgery Registry, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Monash University Department of Surgery, Central Clinical School, Alfred Health, Melbourne, Victoria, Australia.
  • Oesophago-Gastric and Bariatric Unit, Alfred Health, Melbourne, Victoria, Australia.
  • School of Public Health, Monash University, Melbourne, Victoria, Australia.
  • Department of Anaesthesiology and Perioperative Medicine, Monash University, Melbourne, Victoria, Australia.
  • Discipline of Surgery, Medical School, The University of Western Australia, Perth, Western Australia, Australia.

ORCID-Profile: Wendy A Brown, Susannah Ahern, Jennifer Reilly

Förderung

  • Australian Government
  • Applied Medical
  • Johnson and Johnson
  • Avant Foundation
  • Apollo
  • Medtronic Foundation
  • W. L. Gore and Associates

Zitieren

APA

Brown, W. A., Brown, D. L., Holland, J. F., Campbell, A., Cottrell, J., Ahern, S., Reilly, J., Garduce, P., Wetter, J., Hamdorf, J. M., Talbot, M., Baker, S., MacCormick, A. D., & Caterson, I. D. (2025). Metabolic bariatric surgery generates substantial, sustained weight loss and health improvement in a real‐world setting. ANZ Journal of Surgery. https://doi.org/10.1111/ans.19378

Vancouver

Brown WA, Brown DL, Holland JF, Campbell A, Cottrell J, Ahern S, et al. Metabolic bariatric surgery generates substantial, sustained weight loss and health improvement in a real‐world setting. ANZ Journal of Surgery. 2025. doi:10.1111/ans.19378

BibTeX
@article{Brown2025,
  author = {Brown, Wendy A and Brown, Dianne L and Holland, Jennifer F and Campbell, Angus and Cottrell, Jenifer and Ahern, Susannah and Reilly, Jennifer and Garduce, Patrick and Wetter, James and Hamdorf, Jeffrey M and Talbot, Michael and Baker, Samuel and MacCormick, Andrew D and Caterson, Ian D},
  title = {Metabolic bariatric surgery generates substantial, sustained weight loss and health improvement in a real‐world setting},
  journal = {ANZ Journal of Surgery},
  year = {2025},
  doi = {10.1111/ans.19378}
}
Kostenlos starten →